Abstract
CRISPR/Cas9-based genomic engineering allows for simultaneous genome edits to introduce different pathogenic genetic variants and decipher the connection points between their functional consequences. The application of this genomic editing platform in human induced pluripotent stem cell (hiPSC) lines can lead to the investigation of genes and cell types associated with neurodevelopmental …